Drug name…or Star Wars planet?
Prescription drugs have weird names. But so do planets in the Star Wars universe. We asked CNBC staffers whether they could tell the difference.
02:04
Fri, Apr 10 20159:30 AM EDT
Similar Posts
India and Japan see big international investing inflows while investors flee China
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Dave Mann, global head of product and capital markets at Franklin Templeton, joins CNBC’s Bob Pisani on ‘Halftime Report’ to discuss the opportunity investors should keep an eye on overseas.
New tech expected from Apple
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email CNBC’s Morgan Brennan and Piper Jaffray Senior Research Analyst Gene Munster discuss Apple’s next possible moves following expectations of an online television service from tech giant. 04:00 Wed, Mar 18 20159:00 AM EDT
Will restaurants look to chicken in 2024?
CNBC’s Kate Rogers on the success some restaurants have seen with chicken offerings in the last year in the face of stubborn inflation.
Signify CEO: Our next assignment is reducing our cost base
Eric Rondolat, CEO of Signify, discusses the company’s full-year sales, restructuring and cautious 2024 outlook.
Expect four rate cuts in 2024
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email The Exchange Diane Swonk, KPMG chief economist, joins ‘The Exchange’ to discuss cooling inflation, timeline for rate cuts, and more. 02:49 3 hours ago
Citi's Max Layton on oil: Not expecting significant upside from Red Sea attacks
Max Layton, Citi global head of commodities research, joins ‘Money Movers’ to discuss what’s putting the entire commodities sector at risk, how what’s happening in the Red Sea impacts what’s happening in the oil sector, and more.